The Arthur E. Schwarting Symposium is an educational conference focused on pharmacy practice for pharmacists in many settings.
This year's sympoisum had an overall topic of Drug Induced Disease from a Patient Safety perspective. This presentation deals with drug induced psychiatric issues.
Learning Objectives
| The activity met the following learning objectives for Pharmacists: |
| · Identify features of drug-induced psychosis and differentiate between drug-induced psychosis vs. psychosis associated with a medical or mental illness |
| · Articulate which substances are most likely to contribute to psychotic symptoms, including prescription medications, over-the-counter medications, and illicit substances |
| · Apply knowledge of drug-induced psychosis to patient case examples |
Session Offered
Released: May 13, 2021
Expires: May 13, 2024
Course Fee
$15 Pharmacist
ACPE UAN Codes
0009-0000-21-008-H05-P
Session Code
21RW08-JPX68
Accreditation Hours
1.0 hours of CE
Accreditation Statement
| The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |  |
Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive 1.0 CE Hour for completing the activity (ACPE UAN 0009-0000-21-008-H05-P), passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.
Grant Funding
There is no grant funding for this activity.
Faculty
Kristin Waters, PharmD, , BCPPS, BCPS
Assistant Clinical Professor
University of Connecticut School of Pharmacy
Storrs, CT
Faculty Disclosure
Dr. Waters has no financial relationships with any ineligible company associated with these presentations.
Disclaimer
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.
Content
Handouts
Post Test Pharmacist
1. Which of the following is true about psychosis?
A. It occurs only in the context of schizophrenia or bipolar disorder
B. It includes symptoms such as anhedonia and constricted affect
C. It is a symptom, not an illness
D. People without mental illness will not experience a psychotic episode
2. Which of the following stimulants is most likely to induce psychosis?
A. Concerta
B. Ritalin
C. Provigil
D. Adderall
3. Which of the following is true about corticosteroid-induced neuropsychiatric disorder?
A. Risk increases with increasing corticosteroid dose
B. It is a risk with oral or injectable corticosteroids, but not inhaled formulations
C. It is more common in male patients
D. If a patient has tolerated a corticosteroid in the past, there is less of a chance the patient will develop neuropsychiatric symptoms
4. Which of the following comorbidities increases the risk that a patient develops anticholinergic-induced psychosis?
A. Dementia
B. Schizophrenia
C. Renal dysfunction
D. Diabetes mellitus
5. Which of the following medications should be discontinued first if a patient develops Parkinson’s disease psychosis?
A. Pramipexole
B. Selegiline
C. Entacapone
D. L-dopa
KR is a 53 year-old female with no previous psychiatric history. Her past medical history includes hypothyroidism and hypertension. She presents to the emergency department with her husband and states that the FBI has been watching her through her computer for the past week and that she can hear them giving her secret instructions that her husband cannot hear.
All labs are WNL and her urine toxicology screen is negative.
6. Which of the following patient factors may indicate that KR’s psychotic symptoms are NOT associated with a mental illness?
A. The severity of her psychosis
B. Her age at onset of psychosis
C. Her comorbid hypothyroidism
D. The duration of her psychosis
KR’s current medication include the following:
Medication Indication Duration of Treatment
Acetaminophen 650 mg po q6h prn Headache, body aches 3 months
Amlodipine 10 mg po daily Hypertension 1 month
Levothyroxine 37.5 mcg po daily Hypothyroidism 2 years
Lisinopril 10 mg po daily Hypertension 1 year
Metoprolol XL 50 mg po daily Hypertension 1 month
7. Which of KR’s medications is most likely to be contributing to her current presentation?
A. Acetaminophen
B. Amlodipine
C. Lisinopril
D. Metoprolol XL
A 14 year-old male patient is brought to the ED by his parents who are very concerned. He has been saying that he does not “feel real” and has been experiencing auditory, visual, and tactile hallucinations. He was recently started on Adderall XR for ADHD. His parents insist that he does not use illicit drugs or alcohol, however his Utox is positive for PCP.
8. Which of the following may be responsible for the patient’s symptoms?
A. New prescription for Adderall XR
B. Overuse of dextromethorphan
C. PCP use
D. All of the above are possible
9. Dextromethorphan has a similar mechanism of action as which of the following drugs:
A. Ketamine
B. Cocaine
C. Methamphetamine
D. LSD
10. The compounds commonly utilized in weight-loss products may have qualities similar to which of the following drugs:
A. Cocaine
B. PCP
C. Amphetamine
D. Heroin